SPRY icon

ARS Pharmaceuticals
SPRY

Overview Fund Activity

113 hedge funds and large institutions have $612M invested in ARS Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 36 increasing their positions, 27 reducing their positions, and 14 closing their positions.

Holders
113
Holders Change
+13
Holders Change %
+13%
% of All Funds
1.64%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
27
Increased
36
Reduced
27
Closed
14
Calls
$6.42M
Puts
$1.02M
Net Calls
+$5.4M
Net Calls Change
+$3.76M

Top Buyers

1
RCM
1
RA Capital Management
Massachusetts
$111M
2
State Street
2
State Street
Massachusetts
$16.4M
3
PA
3
Perceptive Advisors
New York
$8.86M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$29.5M
5
Invesco
5
Invesco
Georgia
$4.2M

Top Sellers

1
CST
1
Charles Schwab Trust
Nevada
$0
2
Franklin Resources
2
Franklin Resources
California
$30.2M
3
BBA
3
Baker Bros. Advisors
New York
$0
4
NCM
4
Nantahala Capital Management
Connecticut
$0
5
KPF
5
K2 Principal Fund
Ontario, Canada
$22.7M
Name Holding Trade Value Shares
Change 		Shares
Change %
SSA
126
Schonfeld Strategic Advisors
New York
– -$90.4K -16,500 Closed
A
127
AJOVista
Massachusetts
– -$42.9K -7,822 Closed
2 3 4 5
6